Department of Health and Human Services
200 Independence Avenue, S.W.
180 articles with Department of Health and Human Services
Today, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration took actions to help provide safe, effective, and more affordable drugs
JAMA Study Co-Authored by the U.S. Department of Health & Human Services (HHS) and Millennium Health Uncovers Significant Increase in Drug Use Amid COVID-19 Pandemic
A study co-authored by the U.S. Department of Health & Human Services and Millennium Health published in JAMA highlights a national increase in urine drug test positivity rates during COVID-19 for fentanyl, methamphetamine, cocaine, and heroin.
U.S. Department of Health and Human Services Awards Local Community Health Centers to Support Response in Emergencies
Seven members of Health Center Partners of Southern California (HCP) received from the U.S. Department of Health and Human Services, Health Resources Services Administration, a combined total of more than $1.2 million in constr
Last week, HHS Secretary Alex Azar assumed all final authority in deciding new rules regarding food, medical devices and new medications.
Federal Government Announcements Offer Significant COVID-19 Relief and Support for the Senior Living Industry
The U.S. Department of Health and Human Services (HHS) recently announced a private pay distribution from the CARES Act provider relief funds for licensed assisted living providers.
U.S. Government Exercises Option To Purchase Additional RAPIVAB® from BioCryst for Delivery to Strategic National Stockpile
BioCryst Pharmaceuticals, Inc. announced that the U.S. Department of Health and Human Services has exercised its option to purchase an additional 10,000 doses of BioCryst’s approved antiviral influenza therapy, RAPIVAB®, for approximately $7 million.
Nationwide Kidney Risk Campaign Relaunches by National Kidney Foundation, U.S. Department of Health and Human Services, and American Society of Nephrology
The National Kidney Foundation is joining forces with the U.S. Department of Health and Human Services, the American Society of Nephrology, and actor, activist and entrepreneur Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease.
MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness
MediWound Ltd. and its U.S. commercial partner Vericel Corporation announced that the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has accepted the first shipment of NexoBrid® as part of its mission to build national preparedness for public health emergencies.
The Department of Health and Human Services (HHS) OCIO, Office of Executive Service (OES) awarded Aveshka a three-year, $6.3 million contract to help HHS meet and improve compliance with Section 508 requirements. Section 508 mandates federal agencies to ensure information and communications technology is accessible to both government
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
Delta Dental provides critical support to ensure America's dentists receive much-needed federal relief funding
Delta Dental Plans Association applauded the U.S. Department of Health and Human Services' action to make federal relief funding available for dentists harmed by the COVID-19 pandemic.
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
Company Finalizes Initial Pandemic Order for 50 Million Injection Devices to Support Operation Warp Speed Vaccination Program
New Report Reveals Prevalence of Hidden Copay Accumulator Insurance Programs and Higher Costs for People Living with HIV/AIDS and Chronic Diseases
The AIDS Institute Releases Analysis Showing 33 States and Washington, D.C. Have at Least One Insurer With a Copay Accumulator Program Health Plan
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, announced the deliveries of oral TPOXX® to the U.S. Department of Health and Human Services.
MBio Diagnostics and BARDA Partner on a 5-minute, Quantitative Point-of-Care COVID-19 Antibody Panel
MBio Diagnostics announced it has been awarded a $629,595 contract from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to develop and commercialize their point-of-care multiplex serology test for the detection of human anti-SARS-CoV-2 antibodies.
The Department of Health and Human Services finalized a rule that revises 2016 provisions of the Obamacare section 1557 rule that had redefined discrimination "on the basis of sex" to include "gender identity" and "pregnancy termination."
Quidel Corporation announced that Quidel has received funding from the Biomedical Advanced Research and Development Authority to support the development of a point-of-care diagnostic assay that potentially tests for four respiratory viruses: SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus.
RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services
RenovaCare, Inc. announced the appointment of its first Chief Medical Officer, Jo Ellen Schweinle, MD, distinguished former Senior Medical Officer at the U.S. Department of Health and Human Services; Senior Clinical Director at Bayer Corporation, GlaxoSmithKline, McNeil Pharmaceuticals, Chiron/Novartis, and VP Medical Affairs at Axcan Pharma.
Meabco Awarded a $5.9 Million US Government Contract to Advance its BP-C2 Compound as a Medical Countermeasure for Cutaneous Radiation Injuries
Award from the National Institute of Allergy and Infectious Diseases (NIAID) Radiation and Nuclear Countermeasures Program
Mallinckrodt Will Appeal District Court Ruling in Case Involving Ongoing Acthar Medicaid Drug Rebate Dispute with the Centers for Medicare and Medicaid Services (CMS)
Company believes District Court decision misinterprets federal law and fails to address important legal requirements of the Administrative Procedure Act